The Board Meeting to be held on 22/05/2026 has been revised to 21/05/2026 The Board Meeting to be held on 22/05/2026 has been revised to 21/05/2026

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+10.2%1-day move

₹29.55

prior close

₹30.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0-3.3+10.2+15.7+13.4+16.8+19.3+18.6+18.4+24.4+42.1—

Up moveDown movePending

AI summary

Sudarshan Pharma Industries has pre-poned its Board Meeting from May 22, 2026 to May 21, 2026. The key agenda includes migration of the company's equity shares from BSE's SME Platform to the Main Board of BSE, as well as listing on the Main Board of NSE (National Stock Exchange of India). The company will also issue a Postal Ballot Notice to seek shareholder approval for these migration proposals. This move indicates the company is mature enough for main board listing.

Likely market impact

Migration from SME to Main Board is typically positive for shareholders as it increases visibility, liquidity, and institutional investor interest. Dual listing on BSE and NSE main boards could attract more capital flows and improve price discovery.